Skip to main content
. Author manuscript; available in PMC: 2023 Sep 27.
Published in final edited form as: Nanomedicine. 2023 Aug 24;53:102705. doi: 10.1016/j.nano.2023.102705

Figure 1:

Figure 1:

Evaluation of apolipoprotein mimetic peptides in vitro. Solubilization of sphingomyelin vesicles during 2-hour incubation with 5mg/mL apolipoprotein mimetic peptides measured by reduction in turbidity at 600nm (A). Sphingomyelin efflux from ASMD fibroblasts after 24-hour treatment with 10μM or 100μM peptide (B). Viability of ASMD patient cells following 24-hour treatment with peptides. (C). *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, n.s. not significant. N=3